BFRI
Biofrontera Inc

8,746
Mkt Cap
$9.42M
Volume
74,046.00
52W High
$1.87
52W Low
$0.536
PE Ratio
-0.45
BFRI Fundamentals
Price
$0.7536
Prev Close
$0.809
Open
$0.81
50D MA
$0.9821
Beta
0.58
Avg. Volume
97,011.39
EPS (Annual)
-$3.22
P/B
-3.65
Rev/Employee
$401,301.08
Loading...
Loading...
Biofrontera, Inc. is a biopharmaceutical company, which engages in the commercialization of pharmaceutical products. It specializes in the treatment of dermatological conditions, caused primarily by exposure to sunlight that results in sun damage to the skin. The company focuses on the treatment of actinic keratosis and markets a topical antibiotic for treatment of impetigo. Its products include Ameluz and Xepi, its two prescription drugs, and BF-RhodoLED, a lamp used with Ameluz, for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company was founded on March 3, 2015 and is headquartered in Woburn, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
93

Frequently Asked Questions

What is Market Cap of Biofrontera Inc?
What is the 52-week high for Biofrontera Inc?
What is the 52-week low for Biofrontera Inc?
What is Biofrontera Inc stock price today?
What was Biofrontera Inc stock price yesterday?
What is the PE ratio of Biofrontera Inc?
What is the Price-to-Book ratio of Biofrontera Inc?
What is the 50-day moving average of Biofrontera Inc?
How many employess does Biofrontera Inc has?

Latest BFRI News

View

Advertisement|Remove ads.

Advertisement|Remove ads.